UroGen Pharma Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-9.6M | $-9.8M | $271.0K | $6.3M |
| FY2018 | $-37.3M | $-37.9M | $560.0K | $30.6M |
| FY2019 | $-71.0M | $-71.3M | $325.0K | $30.0M |
| FY2020 | $-105.9M | $-107.1M | $1.2M | $28.0M |
| FY2021 | $-84.9M | $-85.6M | $752.0K | $23.1M |
| FY2022 | $-87.6M | $-87.8M | $254.0K | $10.6M |
| FY2023 | $-76.4M | $-76.6M | $194.0K | $9.3M |
| FY2024 | $-96.8M | $-97.1M | $295.0K | $13.1M |
| FY2025 | $-162.4M | $-162.7M | $289.0K | $12.0M |